| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |